Abstract
Machine learning and single-cell data inform personalized drug combinations that selectively co-inhibit cancer cell populations.
All Related Versions
Funding Information
  • Helse Sør-Øst RHF (2020026)
  • Novo Nordisk Foundation Center for Basic Metabolic Research (NNF17CC0027852)
  • Business Finland
  • Research Council of Finland (310507, 313267, 326238, 344698)
  • Research Council of Finland (1320185)
  • Finnish Medical Foundation
  • Sigrid Juselius Foundation
  • Cancer Society of Finland

This publication has 68 references indexed in Scilit: